243 filings
Page 3 of 13
8-K
j5a54kb7
30 Jul 13
Other Events
12:00am
DEFA14A
hb48i1obrdoh3ifctw
30 Jul 13
Additional proxy soliciting materials
12:00am
8-K
wagwk
30 Jul 13
Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals
12:00am
8-K
f5vmd
13 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
voj iqvomxgrrqtj
9 May 13
Optimer Reports First Quarter 2013 Financial Results
12:00am
8-K
apai1m72wl 0u
8 May 13
Entry into a Material Definitive Agreement
12:00am
CT ORDER
7gdn efsc
23 Apr 13
Confidential treatment order
12:00am
DEFA14A
kz90khs0rask 6t8hq
19 Apr 13
Additional proxy soliciting materials
12:00am
ARS
30jjrwv wlrr
15 Apr 13
Annual report to shareholders
12:00am
8-A12B
om5rir 7vpvp
1 Mar 13
Registration of securities on exchange
12:00am
NT 10-K
s4ah1ih
1 Mar 13
Notice of late annual filing
12:00am
8-K
szwkhx fg0nvlyo
28 Feb 13
Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
12:00am
8-K
njw29x6w d8
27 Feb 13
Optimer Pharmaceuticals’ Board of Directors Appoints
12:00am
8-K
rzlw5enoc
25 Jan 13
Departure of Directors or Certain Officers
12:00am
8-K
wtnqw
7 Jan 13
Optimer Pharmaceuticals Reports Preliminary 2012 Gross Product Sales of $74.4 Million
12:00am
CT ORDER
pwqkxbuw
31 Dec 12
Confidential treatment order
12:00am
8-K
98xbbx
11 Dec 12
Departure of Directors or Certain Officers
12:00am